Early Arrhythmia Detection

Projected cardiovascular costs are set to quadruple, rising from $393B to $1.49T by 2050, with stroke leading the surge. 1

Undiagnosed Afib caused 1 in 4 ischemic strokes in older adults2, driving preventable costs and outcomes for patients and members. For risk-bearing organizations, early detection isn't optional, it's essential for clinical and financial performance.

Healthcare, elderly woman with nurse with breakfast at her home and at the table in living room. Support or communication, caregiver and conversation with medical person with senior or old female

iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions.

Lower cost intervention with the Zio monitor service today may prevent high-cost interventions later.3,4

Zio long-term continuous monitoring (LTCM) service, is associated with:

Compared with all other monitoring services, Zio LTCM service was associated with the highest diagnostic yield and lowest retest likelihood.4-7
fpo

Transforming the way cardiac arrhythmias are diagnosed

As a market leader in cardiology diagnostics and arrhythmia detection, iRhythm has served over 10 million patient reports9 processed and posted over 2 billion hours of curated heartbeat data.13

 

We’re on a mission to address the future of healthcare, partnering with risk-based organizations to detect and prevent cardiovascular disease - all while helping you save money and save lives.

Who We Serve

Value-based primary care

Accountable Care Organizations (ACOs)

Clinically Integrated Networks (CINs)

Health assessment organizations

Healthcare enablers

Payers/Payviders

Improve Key Performance Measures

Healthcare Effectiveness Data and Information Set (HEDIS) Measures + Cardiovascular Health

By integrating proactive surveillance for heart arrhythmias into routine care, you have the opportunity to drive better patient outcomes and impact key HEDIS measures related to cardiovascular health.

Lead the future of care. Talk to us about early arrhythmia detection that delivers impact.

  1. Kazi et al. Forecasting the economic burden of cardiovascular disease and stroke in the united states through 2050: A presidential advisory from the american heart association. Circulation. 2024;150(4):e89-e101. doi:10.1161/CIR.0000000000001258
  2. Turakhia et al. Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States. Clinical Cardiology. 2023;46(5):484-493. doi:https://doi.org/10.1002/clc.23983
  3. Heidenreich et al. Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association. Circulation: Heart Failure. 2013;6(3):606-619. doi:https://doi.org/10.1161/hhf.0b013e318291329a
  4. Alkhouli et al. Burden of atrial fibrillation–associated ischemic stroke in the United States. JACC: Clinical Electrophysiology. 2018;4(5):618-625. doi:10.1016/j.jacep.2018.02.021
  5. Reynolds et al. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Am Heart J. 2024;269:25–34. Accessed January 2, 2024. https://doi.org/10.1016/j.ahj.2023.12.002
  6. A specified arrhythmia refers to an arrhythmia encounter diagnosis as per Hierarchical Condition Categories (HCC) 96.
  7. Based on previous generation Zio XT device data. Zio monitor utilizes the same operating principles and ECG algorithm. Additional data on file.
  8. Zio LTCM service refers to Zio XT and Zio monitor service.
  9. Russo P, Coetzer H, Hendrickson EM, Boyle K, Wright B. Assessment of variation in ambulatory cardiac monitoring among commercially insured patients. Am J Manag Care. Published online August 13, 2025. doi:10.37765/ajmc.2026.89782
  10. CV events were defined by the study protocol.
  11. Zio LTCM service refers to Zio XT and Zio monitor service.
  12. Data on file. iRhythm Technologies. 2025.
  13. Data on file. iRhythm Technologies, 2024.

WEB0015.02